Fund
KEGA
VEGA
APVV
ESIF
COST
H2020
Erasmus+
EHP
EFSA
IGA
INTERREG
HUSKROUA
Other
Visegrad Fund
NAWA
POO
SAIA
HORIZON
EU4H
Year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
Older
 
Reg. No.
Year From 
Year To 
Project / grant name  
Fund
Reg. No.
Fund - Period
Project / grant name
APVV-23-0005
2024
2028
Microbiome modulators for maintaining dermal health in animals
APVV
APVV-23-0005
APVV - 2024 - 2028
Microbiome modulators for maintaining dermal health in animals
APVV-23-0360
2024
2027
Innovative biopolymer materials with natural additives for the treatment of burns and chronic wounds
APVV
APVV-23-0360
APVV - 2024 - 2027
Innovative biopolymer materials with natural additives for the treatment of burns and chronic wounds
09I01-03-V02-00109
2024
2024
Support for project preparation in Horizon Europe - UVLF_1
POO
09I01-03-V02-00109
POO - 2024 - 2024
Support for project preparation in Horizon Europe - UVLF_1
9I03-03-V06-00025
2024
2025
Modernization of the infrastructure for research into non-antibiotic approaches to the control of mastitis in dairy cows
POO
9I03-03-V06-00025
POO - 2024 - 2025
Modernization of the infrastructure for research into non-antibiotic approaches to the control of mastitis in dairy cows
08I01-20-V04-00006
2024
2025
Renovation of Pavilion P 1 in the UVLF campus in Košice
POO
08I01-20-V04-00006
POO - 2024 - 2025
Renovation of Pavilion P 1 in the UVLF campus in Košice
IGA-ESGV/09/2024
2024
2026
The role of wild carnivore animals in the circulation of canine parvovirus type 2 (CPV-2) in Slovakia
POO
IGA-ESGV/09/2024
POO - 2024 - 2026
The role of wild carnivore animals in the circulation of canine parvovirus type 2 (CPV-2) in Slovakia
ESGV/01/2024
2024
2026
New methods of post-harvest processing of specialty coffee - benefits and potential risks
IGA
ESGV/01/2024
IGA - 2024 - 2026
New methods of post-harvest processing of specialty coffee - benefits and potential risks
09I03-03-V05-00017
2024
2026
SK: Early stage granty - UVLF
POO
09I03-03-V05-00017
POO - 2024 - 2026
SK: Early stage granty - UVLF
IGA-ESGV/07/2024
2024
2026
Evaluation of the angiogenic potential of innovative porous biomaterials developed for bone tissue regeneration using alternative in vitro and in vivo methods.
IGA
IGA-ESGV/07/2024
IGA - 2024 - 2026
Evaluation of the angiogenic potential of innovative porous biomaterials developed for bone tissue regeneration using alternative in vitro and in vivo methods.
IGA-ESGV/08/2024
2024
2026
The innate antivirus response of human astrocytes after tick-borne orbivirus infection
IGA
IGA-ESGV/08/2024
IGA - 2024 - 2026
The innate antivirus response of human astrocytes after tick-borne orbivirus infection
Number of records in database: 471
Page 6 / 48